2025年4月18日 周五
Home > Archive>Volume 31, Issue 10, 2023 >901-908
PDF HTML XML Export Cite reminder
Research progress of trimethylamine N-oxide in atherosclerosis
CSTR:
[cstr]
Author:
Affiliation:

1.Department of Basic Medicine, School of Medicine, Qinghai University, Xi'ning, Qinghai 810016;2.Qinghai Cardiovascular and Cerebrovascular Specialist Hospital, Xi'ning, Qinghai 810016, China)

Clc Number:

R543.3

  • Article
    • | |
  • Metrics
    • |
  • Reference [61]
    • |
  • Related
    • | | |
  • Comments
    Abstract:

    Intestinal bacteria produce metabolites such as trimethylamine N-oxide (TMAO), which have been found to impact the pathological process of coronary artery atherosclerotic disease through various signaling pathways. TMAO has been shown to induce vascular endothelial cell damage, contribute to lipid deposition in the vascular wall, promote inflammation, and stimulate smooth muscle cell aging and migration. Research suggests that modulation of TMAO metabolism and associated signaling pathways may offer potential therapeutic interventions for the prevention and treatment of atherosclerotic disease. This article will provide a brief overview of the TMAO mechanism in atherosclerosis, offering new research insights for the prevention and treatment of this disease.

    Reference
    [1] 中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2021概要.心脑血管病防治, 2,2(4):20-6,0.Chinese Cardiovascular Health and Disease Report Writing Group.Report on cardiovascular health and diseases in China 2021:an updated summary.Cardio-Cerebrovasc Dis Prev Treat, 2,2(4):20-6,0.
    [2] KOETH R A, WANG Z N, LEVISON B S, et al.Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.Nat Med, 3,9(5):576-585.
    [3] ZHU W, BUFFA J A, WANG Z, et al.Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.J Thromb Haemost, 8,6(9):1857-1872.
    [4] BENSON T W, CONRAD K A, LI X S, et al.Gut microbiota-derived trimethylamine N-oxide contributes to abdominal aortic aneurysm through inflammatory and apoptotic mechanisms.Circulation, 3,7(14):1079-1096.
    [5] QIU L, TAO X Y, XIONG H, et al.Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice.Food Funct, 8,9(8):4299-4309.
    [6] QIU L, YANG D, TAO X Y, et al.Enterobacter aerogenes ZDY01 attenuates choline-induced trimethylamine N-oxide levels by remodeling gut microbiota in mice.J Microbiol Biotechnol, 7,7(8):1491-1499.
    [7] ZHU B T, REN H, XIE F, et al.Trimethylamine N-oxide generated by the gut microbiota:potential atherosclerosis treatment strategies.Curr Pharm Des, 2,8(35):2914-2919.
    [8] GREGORY J C, BUFFA J A, ORG E, et al.Transmission of atherosclerosis susceptibility with gut microbial transplantation.J Biol Chem, 5,0(9):5647-5660.
    [9] SELDIN M M, MENG Y, QI H, et al.Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-κB .J Am Heart Assoc, 6,5(2):e002767.
    [10] MA G H, PAN B, CHEN Y, et al.Trimethylamine N-oxide in atherogenesis:impairing endothelial self-repair capacity and enhancing monocyte adhesion.Biosci Rep, 7,7(2):BSR20160244.
    [11] CHENG X Y, QIU X H, LIU Y K, et al.Trimethylamine N-oxide promotes tissue factor expression and activity in vascular endothelial cells:a new link between trimethylamine N-oxide and atherosclerotic thrombosis.Thromb Res, 9,7:110-116.
    [12] GENG J, YANG C C, WANG B J, et al.Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway .Biomed Pharmacother, 8,7:941-947.
    [13] YANG M A, KHOLMUKHAMEDOV A, SCHULTE M L, et al.Platelet CD36 signaling through ERK5 promotes Caspase-dependent procoagulant activity and fibrin deposition in vivo.Blood Adv, 8,2(21):2848-2861.
    [14] CHEN M L, ZHU X H, RAN L, et al.Trimethylamine-N-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway.J Am Heart Assoc, 7,6(9):e006347.
    [15] 乔莞宁, 陈虹印, 张扬.氧化应激与动脉粥样硬化.中国动脉硬化杂志, 3,1(4):312-321.QIAO G N, CHEN H Y, ZHANG Y.Oxidative stress and atherosclerosis.Chin J Arterioscler, 3,1(4):312-321.
    [16] SUN X L, JIAO X F, MA Y R, et al.Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome.Biochem Biophys Res Commun, 6,1(1/2):63-70.
    [17] 王玉香, 燕燕, 李永芳, 等.沉默MAP4K4通过调控PPARγ/ABCA1通路缓解ox-LDL诱导的血管内皮细胞损伤.中国动脉硬化杂志, 1,9(1):54-59.WANG Y X, YAN Y, LI Y F, et al.Silencing of MAP4K4 alleviated ox-LDL-induced vascular endothelial cell injury via regulating PPARγ/ABCA1 signaling.Chin J Arterioscler, 1,9(1):54-59.
    [18] BRUNT V E, GIOSCIA-RYAN R A, CASSO A G, et al.Trimethylamine-N-oxide promotes age-related vascular oxidative stress and endothelial dysfunction in mice and healthy humans.Hypertension, 0,6(1):101-112.
    [19] WU P, CHEN J N, CHEN J J, et al.Trimethylamine N-oxide promotes ApoE－/－ mice atherosclerosis by inducing vascular endothelial cell pyroptosis via the SDHB/ROS pathway.J Cell Physiol, 0,5(10):6582-6591.
    [20] LIU X, SHAO Y J, TU J Z H, et al.Trimethylamine-N-oxide-stimulated hepatocyte-derived exosomes promote inflammation and endothelial dysfunction through nuclear factor-kappa B signaling.Ann Transl Med, 1,9(22):1670.
    [21] OU Z J, CHEN J, DAI W P, et al.25-Hydroxycholesterol impairs endothelial function and vasodilation by uncoupling and inhibiting endothelial nitric oxide synthase.Am J Physiol Endocrinol Metab, 6,1(4):E781-E790.
    [22] SELDIN M M, MENG Y H, QI H X, et al.Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-κB.J Am Heart Assoc, 6,5(2):e002767.
    [23] WITKOWSKI M, WITKOWSKI M, FRIEBEL J, et al.Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis.Cardiovasc Res, 2,8(10):2367-2384.
    [24] QUERIO G, ANTONIOTTI S, GEDDO F, et al.Trimethylamine N-oxide (TMAO) impairs purinergic induced intracellular calcium increase and nitric oxide release in endothelial cells.Int J Mol Sci, 2,3(7):3982.
    [25] YU X H, ZHANG D W, ZHENG X L, et al.Cholesterol transport system:an integrated cholesterol transport model involved in atherosclerosis.Prog Lipid Res, 9,3:65-91.
    [26] DING L, CHANG M R, GUO Y, et al.Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism .Lipids Health Dis, 8,7(1):286.
    [27] WARRIER M, SHIH D M, BURROWS A C, et al.The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance.Cell Rep, 5,0(3):326-338.
    [28] WANG Z N, ROBERTS A B, BUFFA J A, et al.Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis.Cell, 5,3(7):1585-1595.
    [29] ROBERTS A B, GU X D, BUFFA J A, et al.Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential.Nat Med, 8,4(9):1407-1417.
    [30] KUKA J, LIEPINSH E, MAKRECKA-KUKA M, et al.Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.Life Sci, 4,7(2):84-92.
    [31] ANWAR S, BHANDARI U, PANDA B P, et al.Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk.J Pharm Biomed Anal, 8,9:100-112.
    [32] TREACY E P, AKERMAN B R, CHOW L M, et al.Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication.Hum Mol Genet, 8,7(5):839-845.
    [33] YANG S J, LI X Y, YANG F, et al.Gut microbiota-dependent marker TMAO in promoting cardiovascular disease:inflammation mechanism, clinical prognostic, and potential as a therapeutic target.Front Pharmacol, 9,0:1360.
    [34] WANG Z N, KLIPFELL E, BENNETT B J, et al.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.Nature, 1,2(7341):57-63.
    [35] MOHAMMADI A, VAHABZADEH Z, JAMALZADEH S, et al.Trimethylamine-N-oxide, as a risk factor for atherosclerosis, induces stress in J774A.1 murine macrophages.Adv Med Sci, 8,3(1):57-63.
    [36] KRISHNAN-SIVADOSS I, MIJARES-ROJAS I A, VILLARREAL-LEAL R A, et al.Heat shock protein 60 and cardiovascular diseases:an intricate love-hate story.Med Res Rev, 1,1(1):29-71.
    [37] WICK G, JAKIC B, BUSZKO M, et al.The role of heat shock proteins in atherosclerosis.Nat Rev Cardiol, 4,1(9):516-529.
    [38] BOINI K M, HUSSAIN T, LI P L, et al.Trimethylamine-N-oxide instigates NLRP3 inflammasome activation and endothelial dysfunction.Cell Physiol Biochem, 7,4(1):152-162.
    [39] FENG W D, WANG Y, LUO T, et al.Scoparone suppresses mitophagy-mediated NLRP3 inflammasome activation in inflammatory diseases.Acta Pharmacol Sin, 3,4(6):1238-1251.
    [40] REKHI U R, CATUNDA R Q, ALEXIOU M, et al.Impact of a CD36 inhibitor on porphyromonas gingivalis mediated atherosclerosis.Arch Oral Biol, 1,6:105129.
    [41] HU J X, XU J M, SHEN S, et al.Trimethylamine N-oxide promotes abdominal aortic aneurysm formation by aggravating aortic smooth muscle cell senescence in mice.J Cardiovasc Transl Res, 2,5(5):1064-1074.
    [42] SAAOUD F, LIU L, XU K M, et al.Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress/mitochondrial ROS/glycolysis pathways.JCI Insight, 3,8(1):e158183.
    [43] BASATEMUR G L, JRGENSEN H F, CLARKE M C H, et al.Vascular smooth muscle cells in atherosclerosis.Nat Rev Cardiol, 9,6(12):727-744.
    [44] LIU H, JIA K P, REN Z N, et al.PRMT5 critically mediates TMAO-induced inflammatory response in vascular smooth muscle cells.Cell Death Dis, 2,3(4):299.
    [45] ZHANG X L, LI Y N, YANG P Z, et al.Trimethylamine-N-oxide promotes vascular calcification through activation of NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3) inflammasome and NF-κB (nuclear factor κB) signals.Arterioscler Thromb Vasc Biol, 0,0(3):751-765.
    [46] JAWORSKA K, KONOP M, HUTSCH T, et al.Trimethylamine but not trimethylamine oxide increases with age in rat plasma and affects smooth muscle cells viability.J Gerontol A Biol Sci Med Sci, 0,5(7):1276-1283.
    [47] CHEN C Y, LEU H B, WANG S C, et al.Inhibition of trimethylamine N-oxide attenuates neointimal formation through reduction of inflammasome and oxidative stress in a mouse model of carotid artery ligation.Antioxid Redox Signal, 3,8(1/3):215-233.
    [48] CHOU R H, CHEN C Y, CHEN I C, et al.Trimethylamine N-oxide, circulating endothelial progenitor cells, and endothelial function in patients with stable angina.Sci Rep, 9,9(1):4249.
    [49] KE Y L, LI D, ZHAO M M, et al.Gut flora-dependent metabolite trimethylamine-N-oxide accelerates endothelial cell senescence and vascular aging through oxidative stress.Free Radic Biol Med, 8,6:88-100.
    [50] XIE F F, ZHEN X, LIU Z L, et al.Dietary choline, via gut microbe-generated trimethylamine-N-oxide, aggravates chronic kidney disease-induced cardiac dysfunction by inhibiting hypoxia-induced factor 1α.Front Physiol, 2,3:996166.
    [51] BABA O, HUANG L H, ELVINGTON A, et al.CXCR4-binding positron emission tomography tracers link monocyte recruitment and endothelial injury in murine atherosclerosis.Arterioscler Thromb Vasc Biol, 1,1(2):822-836.
    [52] LIU X, SHAO Y J, TU J Z H, et al.TMAO-activated hepatocyte-derived exosomes impair angiogenesis via repressing CXCR4.Front Cell Dev Biol, 1,9:804049.
    [53] GUO M Y, CAI Y, HE C L, et al.Coupled modeling of lipid deposition, inflammatory response and intraplaque angiogenesis in atherosclerotic plaque.Ann Biomed Eng, 9,7(2):439-452.
    [54] KOAY Y C, CHEN Y C, WALI J A, et al.Plasma levels of trimethylamine-N-oxide can be increased with ‘healthy’ and ‘unhealthy’ diets and do not correlate with the extent of atherosclerosis but with plaque instability.Cardiovasc Res, 1,7(2):435-449.
    [55] PARK J E, MILLER M, RHYNE J, et al.Differential effect of short-term popular diets on TMAO and other cardio-metabolic risk markers.Nutr Metab Cardiovasc Dis, 9,9(5):513-517.
    [56] SPENCE J D.Cardiovascular effects of TMAO and other toxic metabolites of the intestinal microbiome.J Intern Med, 3,3(1):2-3.
    [57] MEI Z D, CHEN G C, WANG Z, et al.Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular disease in the Hispanic Community Health Study/Study of Latinos.Am J Clin Nutr, 1,3(6):1503-1514.
    [58] WANG Z N, BERGERON N, LEVISON B S, et al.Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women.Eur Heart J, 9,0(7):583-594.
    [59] KRISHNAN S, O'CONNOR L E, WANG Y, et al.Adopting a mediterranean-style eating pattern with low, but not moderate, unprocessed, lean red meat intake reduces fasting serum trimethylamine N-oxide (TMAO) in adults who are overweight or obese.Br J Nutr, 1,8(9):1-21.
    [60] KOODZIEJ M, SZAJEWSKA H.Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children:a randomized clinical trial.Clin Microbiol Infect, 9,5(6):699-704.
    [61] DU Y, LI X, SU C, et al.The human gut microbiome:a new and exciting avenue in cardiovascular drug discovery.Expert Opin Drug Discov, 9,4(10):1037-1052.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

WANG Yuhuan, WU Qiong, MA Xiaofeng, WANG Shenglan, YANG Hui. Research progress of trimethylamine N-oxide in atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2023,31(10):901-908.

Copy
Share
Article Metrics
  • Abstract:685
  • PDF: 645
  • HTML: 0
  • Cited by: 0
History
  • Received:March 30,2023
  • Revised:June 28,2023
  • Online: November 08,2023
Article QR Code

You are the 32692 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025